Details for Patent: 10,688,244
✉ Email this page to a colleague
Which drugs does patent 10,688,244 protect, and when does it expire?
Patent 10,688,244 protects AUVI-Q and is included in one NDA.
This patent has six patent family members in five countries.
Summary for Patent: 10,688,244
| Title: | Medicament delivery device and methods for delivering drugs to infants and children |
| Abstract: | A method of delivering epinephrine includes placing a distal end surface of a medical injector into contact with a target location of a patient. The medical injector includes a housing, an energy storage member, and a medicament container containing a dose of epinephrine effective for administration to the patient experiencing anaphylaxis and having a weight of less than 15 kg. The medicament container is coupled to a needle. The medical injector is actuated such that the energy storage member produces a force to move the needle from a first needle position to a second needle position. A distal tip of the needle extends from the distal end surface by a distance of between 7 millimeters and 8 millimeters when the needle is in the second needle position. A portion of the force is exerted to expel the dose of epinephrine when the needle is in the second position. |
| Inventor(s): | Edwards; Eric S. (Moseley, VA), Edwards; Evan T. (Charlottesville, VA), Kelley; Glen L. (Glen Allen, VA), Meyers; Paul F. (Fishers, IN) |
| Assignee: | kaleo, Inc. (Richmond, VA) |
| Application Number: | 16/071,203 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Device; Dosage form; |
Drugs Protected by US Patent 10,688,244
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kaleo Inc | AUVI-Q | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 201739-003 | Nov 17, 2017 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | METHOD OF TREATING AN ALLERGIC REACTION USING AN AUTO-INJECTOR | ⤷ Sign Up | |||
| Kaleo Inc | AUVI-Q | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 201739-002 | Aug 10, 2012 | BX | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | METHOD OF TREATING AN ALLERGIC REACTION USING AN AUTO-INJECTOR | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,688,244
| PCT Information | |||
| PCT Filed | December 21, 2017 | PCT Application Number: | PCT/US2017/067873 |
| PCT Publication Date: | June 28, 2018 | PCT Publication Number: | WO2018/119218 |
International Family Members for US Patent 10,688,244
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2017379094 | ⤷ Sign Up | |||
| Canada | 3046228 | ⤷ Sign Up | |||
| European Patent Office | 3558420 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
